Jefferies Group LLC Cure Vac N.V. Call Options Transaction History

Jefferies Group LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	SELL	$49.26 - $74.5 $2.52 Million - $3.81 Million	-51,200 Closed	0 $0
Q2 2021 Sep 21, 2023	BUY	$56.91 - $127.53 $2.91 Million - $6.53 Million	51,200 New	51,200 $3.76 Million
Q2 2021 Aug 20, 2021	SELL	$56.91 - $127.53 $288 Million - $646 Million	-5,068,800 Reduced 99.0%	51,200 $3.76 Million
Q2 2021 Aug 16, 2021	BUY	$56.91 - $127.53 $291 Million - $653 Million	5,120,000 New	5,120,000 $3.76 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $499M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.